Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-24-051264

Director sold 37,161 shares at $6.19 ($229,956)

  • Director acquired 50,001 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jaksch Frank L Jr · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-13 Exercise or conversion : show line 1 in the form +50,001 $3.66 $183,004 281,340 D
2024-12-13 Sale : show line 2 in the form −37,161 $6.19 $229,956 244,179 D
Open-market sales · 37,161 sh · avg $6.19 · $229,956

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-13 Exercise or conversion : show line 3 in the form Employee Stock Options (right to buy) −50,001 0 D
Loading xslF345X05/wk-form4_1734135129.xml…